Research article · 6 Oct 2026
Conference abstractPublished 14 Jul 2014
Development and characterization of a novel polymeric nanomicellar formulation (size 10-15 nm) for intermediate and posterior uveitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To develop Dexamethasone (DEX) loaded polymeric nanomicelles in size range of 10-15 nm for the treatment ofintermediate and posterior uveitis. Methods: A low molecular weight diblockco-polymers (mPEG750-PCL1200) was synthesized by ring opening polymerization usingmPEG as macroinitiator and stannous octoate as catalyst. Polymer was characterized by H1 NMR, IR spectroscopy, gelpermeation chromatography, critical micelle concentration (CMC), and cytotoxicity studies in conjunctival and retinal cell lines. DEX-loaded nanomicelles were prepared by modified film hydration method. In order to achieve an optimizedformulation containing 1 mg/mL DEX, a 2 factors-3 level response surface methodology was generated using SAS 9.02. Theindependent factors were polymer amount (X1) and DEX amount (X2). Solubility of DEX in micelle solution was taken asresponse variable (Y). The optimized formulation was characterized for solubility of DEX, micelle size and PDI, and TEM analysis. The formulation was also subjected to in vitro drug release, in vitro transport across conjunctival cell line and exvivo transport across excised rabbit sclera. Results: The diblock copolymer was successfully synthesized and characterized for structure by H1-NMR and IR spectroscopies. The Mw, Mn and PDI were 1972 Da, 1627 Da and 1.21, respectively. The CMC was 3.87 μg/mL. The model for predicting the DEX solubility was found to be significant and was validated by check point analysis. The optimized nanomicelles exhibited mean size in range of 10-13nm with unimodel size distribution and low polydispersity. The optimized formulations exhibiteda 2 fold increase in DEX permeability across the conjunctival cell line as compared to DEX suspension. The permeability of DEX across the excised rabbit sclera with the nanomicelles was 2.65E-06 cm/sec, which was 2.2 fold higher compared to DEX in suspension. Conclusion: The design of experiment was successfully utilized for predicting the DEX solubility in micellar formulation. Higherpermeability of DEX was observed across both conjunctiva and sclera with nanomicellar formulation. This nanoformulation might have potential to deliver drugs to the posterior segment by noninvasive route.
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Chandramouli Natarajan”
